Zhejiang Shapuaisi Pharmaceutical Co., Ltd. (603168.SH): Shanghai Jingxing reduced its holdings by a total of 1.6619 million shares, the holding period has expired.
Shapuaisi (603168.SH) announced that Shanghai Jingxing plans to reduce its holdings on November 22, 2024...
Zhejiang Shapuaisi Pharmaceutical (603168.SH) announced that the reduction time interval of Shanghai Jingxing's plan to reduce its shareholding in November 22, 2024 has expired. From November 27, 2024 to February 26, 2025, Shanghai Jingxing reduced its shareholding of Zhejiang Shapuaisi Pharmaceutical by 1,661,900 shares through centralized bidding trading.
Related Articles
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
